Caption Management, LLC Gossamer Bio, Inc. Call Options Transaction History

Caption Management, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	BUY	$5.97 - $9.97 $589,239 - $984,039	98,700 New	98,700 $826,000
Q1 2021 May 17, 2021	SELL	$8.63 - $10.94 $1.17 Million - $1.48 Million	-135,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$8.3 - $13.59 $83,000 - $135,900	10,000 Added 8.0%	135,000 $1.31 Million
Q3 2020 Nov 16, 2020	BUY	$11.3 - $14.75 $1.41 Million - $1.84 Million	125,000 New	125,000 $1.55 Million
Q2 2020 Aug 14, 2020	SELL	$9.52 - $15.98 $476,000 - $799,000	-50,000 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$14.82 - $26.79 $1.2 Million - $2.17 Million	-80,900 Reduced 61.8%	50,000 $781,000
Q3 2019 Nov 14, 2019	BUY	$16.02 - $22.47 $2.1 Million - $2.94 Million	130,900 New	130,900 $2.2 Million

108

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $90.2M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.